Sympathetic nervous system, genes and human essential hypertension

Current Neurovascular Research

Volumn 2, Issue 4, 2005, Pages 303-317

  Zhu, Haidong ^a   Poole, Joseph ^a   Lu, Yanhui ^a   Harshfield, Gregory A ^a   Treiber, Frank A ^a   Snieder, Harold ^a,b   Dong, Yanbin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Adrenergic receptors; Blood pressure; Catecholamine; Dopamine receptors; Gene environment interaction; Gene gene interaction; Polymorphisms; Signal transduction

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 4; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; NORADRENALIN TRANSPORTER; PHENYLETHANOLAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CLIMATE; COPING BEHAVIOR; DIET; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; GENE ACTIVATION; GENE INACTIVATION; GENE INTERACTION; GENE SILENCING; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HOSTILITY; HUMAN; LIFESTYLE; PERSONALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; VARIATION (GENETICS);

EID: 24744462517     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720205774322575     Document Type: Review

References (180)

1. Abe, M, Nakura, J, Yamamoto, M, Jin, JJ, Wu, Z, Tabara, Y, Yamamoto, Y, Igase, M, Kohara, K, and Miki, T. (2002) Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension 40(3): 261-5.
2. Albanese, V, Biguet, NF, Kiefer, H, Bayard, E, Mallet, J, and Meloni, R. (2001) Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 10(17): 1785-92.
3. Albrecht, FE, Drago, J, Felder, RA, Printz, MP, Eisner, GM, Robillard, JE, Sibley, DR, Westphal, HJ, and Jose, PA. (1996) Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97(10): 2283-8.
4. Amenta, F, Ricci, A, Rossodivita, I, Avola, R, and Tayebati, SK. (2001) The dopaminergic system in hypertension. Clin Exp Hypertens 23(1-2): 15-24.
5. Asano, M, Masuzawa, K, Matsuda, T, and Asano, T. (1988) Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats. J Pharmacol Exp Ther 246(2): 709-18.
6. Asico, LD, Ladines, C, Fuchs, S, Accili, D, Carey, RM, Semeraro, C, Pocchiari, F, Felder, RA, Eisner, GM, and Jose, PA. (1998) Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 102(3): 493-8.
7. Bachmann, AW, Ballantine, DM, and Gordon, RD. (1993) Effect of positive family history of hypertension on the blood pressure and catecholamine responses to a 6 hour adrenaline infusion. Clin Exp Pharmacol Physiol 20(5): 395-8.
8. Baima, J, Nicolaou, M, Schwartz, F, DeStefano, AL, Manolis, A, Gavras, I, Laffer, C, Elijovich, F, Farrer, L, Baldwin, CT, and Gavras, H. (1999) Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension 34(1): 4-7.
9. Balligand, JL. (1999) Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 43(3): 607-20.
10. Barbeau, P, Litaker, MS, Jackson, RW, and Treiber, FA. (2003) A tyrosine hydroxylase microsatellite and hemodynamic response to stress in a multi-ethnic sample of youth. Ethn Dis 13(2): 186-92.
11. Beige, J, Bellmann, A, Sharma, AM, and Gessner, R. (2004) Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens 17(12 Pt 1): 1184-7.
12. Bek, MJ, Eisner, GM, Felder, RA, and Jose, PA. (2001) Dopamine receptors in hypertension. Mt Sinai J Med 68(6): 362-9.
13. Belfer, I, Buzas, B, Hipp, H, Phillips, G, Taubman, J, Lorincz, I, Evans, C, Lipsky, RH, Enoch, MA, Max, MB, and Goldman, D. (2004) Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet.
14. Bengra, C, Mifflin, TE, Khripin, Y, Manunta, P, Williams, SM, Jose, PA, and Felder, RA. (2002) Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 48(12): 2131-40.
15. Bengtsson, K, Melander, O, Orho-Melander, M, Lindblad, U, Ranstam, J, Rastam, L, and Groop, L. (2001) Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 104(2): 187-90.
16. Bengtsson, K, Orho-Melander, M, Melander, O, Lindblad, U, Ranstam, J, Rastam, L, and Groop, L. (2001) Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37(5): 1303-8.
17. Bray, MS, Krushkal, J, Li, L, Ferrell, R, Kardia, S, Sing, CF, Turner, ST, and Boerwinkle, E. (2000) Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101(25): 2877-82.
18. Busjahn, A, Li, GH, Faulhaber, HD, Rosenthal, M, Becker, A, Jeschke, E, Schuster, H, Timmermann, B, Hoehe, MR, and Luft, FC. (2000) beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35(2): 555-60.
19. Cambien, F, Poirier, O, Nicaud, V, Herrmann, SM, Mallet, C, Ricard, S, Behague, I, Hallet, V, Blanc, H, Loukaci, V, Thillet, J, Evans, A, Ruidavets, JB, Arveiler, D, Luc, G, and Tiret, L. (1999) Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet 65(1): 183-91.
20. Casari, G, Barlassina, C, Cusi, D, Zagato, L, Muirhead, R, Righetti, M, Nembri, P, Amar, K, Gatti, M, Macciardi, F, and et al. (1995) Association of the alpha-adducin locus with essential hypertension. Hypertension 25(3): 320-6.
21. Cavalli, A, Lattion, AL, Hummler, E, Nenniger, M, Pedrazzini, T, Aubert, JF, Michel, MC, Yang, M, Lembo, G, Vecchione, C, Mostardini, M, Schmidt, A, Beermann, F, and Cotecchia, S. (1997) Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci USA 94(21): 11589-94.
22. Chakraborty, BM, Mueller, WH, Reeves, R, Poston, WS, 2nd, Holscher, DM, Quill, B, Hanis, CL, and Foreyt, JP. (2003) Migration history, health behaviors, and cardiovascular disease risk factors in overweight Mexican-American women. Ethn Dis 13(1): 94-108.
23. Chen, Y, Nakura, J, Jin, JJ, Wu, Z, Yamamoto, M, Abe, M, Tabara, Y, Yamamoto, Y, Igase, M, Bo, X, Kohara, K, and Miki, T. (2003) Association of the GNAS1 gene variant with hypertension is dependent on alcohol consumption. Hypertens Res 26(6): 439-44.
24. Chitbangonsyn, SW, Mahboubi, P, Walker, D, Rana, BK, Diggle, KL, Timberlake, DS, Parmer, RJ, and O'Connor, DT. (2003) Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach. J Hum Hypertens 17(5): 319-24.
25. Comings, DE. (2001) Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci 931: 50-83.
26. Comings, DE, Johnson, JP, Gonzalez, NS, Huss, M, Saucier, G, McGue, M, and MacMurray, J. (2000) Association between the adrenergic alpha 2A receptor gene (ADRA2A) and measures of irritability, hostility, impulsivity and memory in normal subjects. Psychiatr Genet 10(1): 39-42.
27. Conner, O. (2004) The catecholamine release-inhibitory peptide catestatin (human CHGA): a naturally occurring amino acid variant (Gly364Ser) causes profound alterations in autonomic activity in humans. Hypertension 44(4): 54.
28. Cooper, RS, Luke, A, Zhu, X, Kan, D, Adeyemo, A, Rotimi, C, Bouzekri, N, and Ward, R. (2002) Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 40(5): 629-33.
29. Corbalan, MS. (2002) The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin Genet 61(4): 305-7.
30. Cotecchia, S, Scheer, A, Diviani, D, Fanelli, F, and De Benedetti, PG. (1998) Molecular mechanisms involved in the activation and regulation of the alpha 1-adrenergic receptor subtypes. Farmaco 53(4): 273-7.
31. Cubells, JF, van Kammen, DP, Kelley, ME, Anderson, GM, O'Connor, DT, Price, LH, Malison, R, Rao, PA, Kobayashi, K, Nagatsu, T, and Gelernter, J. (1998) Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102(5): 533-40.
32. Cui, J, Zhou, X, Chazaro, I, DeStefano, AL, Manolis, AJ, Baldwin, CT, and Gavras, H. (2003) Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. Am J Hypertens 16(10): 859-63.
33. Dao, TT, Kailasam, MT, Farmer, RJ, Le, HV, Le Verge, R, Kennedy, BP, Ziegler, G, Insel, PA, Wright, FA, and O'Connor, DT. (1998) Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. J Hypertens 16(6): 779-92.
34. DiBona, GF. (2000) Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 36(6): 1083-8.
35. DiBona, GF, and Kopp, UC. (1997) Neural control of renal function. Physiol Rev 77(1): 75-197.
36. DiBona, GF, and Sawin, LL. (1983) Renal nerves in renal adaptation to dietary sodium restriction. Am J Physiol 245: F322-F328.
37. Dong, Y. (2000) The G protein beta3 subunit polymorphism in human hypertension. Int J Cardiol 73(2): 197-8.
38. Dong, Y, Wang, X, Zhu, H, Treiber, FA, and Snieder, H. (2004b) Endothelin-1 gene and progression of blood pressure and left ventricular mass: longitudinal findings in youth. Hypertension 44(6): 884-90.
39. Dong, Y, Zhu, H, Sagnella, GA, Carter, ND, Cook, DG, and Cappuccio, FP. (1999) Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 34(6): 1193-6.
40. Dong, Y, Zhu, H, Wang, X, Dalageorgou, C, Carter, N, Spector, TD, and Snieder, H. (2004a) Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 14(7): 419-27.
41. Doyle, AE, Goodman, JE, Silber, PM, and Yager, JD. (2004) Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes. Cancer Lett 214(2): 189-95.
42. Ducher, M, Bertram, D, Pozet, N, Laville, M, and Fauvel, JP. (2002) Stress-induced renal alterations in normotensives offspring of hypertensives and in hypertensives. Am J Hypertens 15(4 Pt 1): 346-50.
43. Eschenhagen, T. (1993) G proteins and the heart. Cell Biol Int 17(8): 723-49.
44. Farfel, Z, Bourne, HR, and Iiri, T. (1999) The expanding spectrum of G protein diseases. N Engl J Med 340(13): 1012-20.
45. Felder, RA, Sanada, H, Xu, J, Yu, PY, Wang, Z, Watanabe, H, Asico, LD, Wang, W, Zheng, S, Yamaguchi, I, Williams, SM, Gainer, J, Brown, NJ, Hazen-Martin, D, Wong, LJ, Robillard, JE, Carey, RM, Eisner, GM, and Jose, PA. (2002) G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99(6): 3872-7.
46. Feldman, RD, Tan, CM, and Chorazyczewski, J. (1995) G protein alterations in hypertension and aging. Hypertension 26(5): 725-32.
47. Ferrier, C, Cox, H, and Esler, M. (1993) Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci (Lond) 84(2): 225-30.
48. Finley, JC Jr, O'Leary, M, Wester, D, MacKenzie, S, Shepard, N, Farrow, S, and Lockette, W. (2004) A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress. J Appl Physiol 96(6): 2231-9.
49. Garenc, C, Perusse, L, Chagnon, YC, Rankinen, T, Gagnon, J, Borecki, IB, Leon, AS, Skinner, JS, Wilmore, JH, Rao, DC, and Bouchard, C. (2002) The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med 8(2): 88-94.
50. Gavras, I, Manolis, AJ, and Gavras, H. (2001) The alpha2 -adrenergic receptors in hypertension and heart failure: experimental and clinical studies. J Hypertens 19(12): 2115-24.
51. Ge, D, Huang, J, He, J, Li, B, Duan, X, Chen, R, and Gu, D. (2005) Beta2-Adrenergic Receptor Gene Variations Associated with Stage-2 Hypertension in Northern Han Chinese. Ann Hum Genet 69(Pt 1): 36-44.
52. Goldstein, DS, and Kopin, IJ. (1990) The autonomic nervous system and catecholamines in normal blood pressure control and hypertension, in: Hypertension: pathophysiology, diagnosis, and management (JH. Laragh, and BM. Brenner, eds.), Raven Press, Ltd, New York, NY, pp. 711-747.
53. Grassi, G. (1998) Role of the sympathetic nervous system in human hypertension. J Hypertens 16(12 Pt 2): 1979-87.
54. Gratze, G, Fortin, J, Labugger, R, Binder, A, Kotanko, P, Timmermann, B, Luft, FC, Hoehe, MR, and Skrabal, F. (1999) Beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33(6): 1425-30.
55. Grimsby, J, Chen, K, Wang, LJ, Lan, NC, and Shih, JC. (1991) Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 88(9): 3637-41.
56. Guimaraes, S, and Moura, D. (2001) Vascular adrenoceptors: an update. Pharmacol Rev 53(2): 319-56.
57. Harshfield, GA, Treiber, FA, Davis, H, and Kapuku, GK. (2002) Impaired stress-induced pressure natriuresis is related to left ventricle structure in blacks. Hypertension 39(4): 844-7.
58. Hein, L, Altman, JD, and Kobilka, BK. (1999) Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402(6758): 181-4.
59. Heinonen, P, Jartti, L, Jarvisalo, MJ, Pesonen, U, Kaprio, JA, Ronnemaa, T, Raitakari, OT, and Scheinin, M. (2002) Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin Sci (Lond) 103(5): 517-24.
60. Helkamaa, T, Mannisto, PT, Rauhala, P, Cheng, ZJ, Finckenberg, P, Huotari, M, Gogos, JA, Karayiorgou, M, and Mervaala, EM. (2003) Resistance to salt-induced hypertension in catechol-O-methyltransferasegene-disrupted mice. J Hypertens 21(12): 2365-74.
61. Henderson, AS, Korten, AE, Jorm, AF, Jacomb, PA, Christensen, H, Rodgers, B, Tan, X, and Easteal, S. (2000) COMT and DRD3 polymorphisms, environmental exposures, and personality traits related to common mental disorders. Am J Med Genet 96(1): 102-7.
62. Hollon, TR, Bek, MJ, Lachowicz, JE, Ariano, MA, Mezey, E, Ramachandran, R, Wersinger, SR, Soares-da-Silva, P, Liu, ZF, Grinberg, A, Drago, J, Young, WS, 3rd, Westphal, H, Jose, PA, and Sibley, DR. (2002) Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22(24): 10801-10.
63. Holschneider, DP, Scremin, OU, Roos, KP, Chialvo, DR, Chen, K, and Shih, JC. (2002) Increased baroreceptor response in mice deficient in monoamine oxidase A and B. Am J Physiol Heart Circ Physiol 282(3): H964-72.
64. Holzman, PS. (2000) Eye movements and the search for the essence of schizophrenia. Brain Res Brain Res Rev 31(2-3): 350-6.
65. Hotamisligil, GS, and Breakefield, XO. (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49(2): 383-92.
66. Hurowitz, EH, Melnyk, JM, Chen, YJ, Kouros-Mehr, H, Simon, MI, and Shizuya, H. (2000) Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes. DNA Res 7(2): 111-20.
67. Hussain, T, Kansra, V, and Lokhandwala, MF. (1999) Renal dopamine receptor signaling mechanisms in spontaneously hypertensive and Fischer 344 old rats. Clin Exp Hypertens 21(1-2): 25-36.
68. Hussain, T, and Lokhandwala, MF. (1998) Renal dopamine receptor function in hypertension. Hypertension 32(2): 187-97.
69. Jia, H, Hingorani, AD, Sharma, P, Hopper, R, Dickerson, C, Trutwein, D, Lloyd, DD, and Brown, MJ. (1999) Association of the G(s)alpha gene with essential hypertension and response to beta-blockade. Hypertension 34(1): 8-14.
70. Johnson, JA, Zineh, I, Puckett, BJ, McGorray, SP, Yarandi, HN, and Pauly, DF. (2003) Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74(1): 44-52.
71. Jonsson, EG, Goldman, D, Spurlock, G, Gustavsson, JP, Nielsen, DA, Linnoila, M, Owen, MJ, and Sedvall, GC. (1997) Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247(6): 297-302.
72. Jordan, J, Lipp, A, Tank, J, Schroder, C, Stoffels, M, Franke, G, Diedrich, A, Arnold, G, Goldstein, DS, Sharma, AM, and Luft, FC. (2002) Catechol-o-methyltransferase and blood pressure in humans. Circulation 106(4): 460-5.
73. Jose, PA, Eisner, GM, and Felder, RA. (2002) Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11(1): 87-92.
74. Jose, PA, Eisner, GM, and Felder, RA. (2003) Dopamine and the kidney: a role in hypertension? Curr Opin Nephrol Hypertens 12(2): 189-94.
75. Julius, S. (1991) Autonomic nervous system dysregulation in human hypertension. Am J Cardiol 67(10): 3B-7B.
76. Ke, X, and Cardon, LR. (2003) Efficient selective screening of haplotype tag SNPs. Bioinformatics 19(2): 287-8.
77. Kelsey, RM, Blascovich, J, Leitten, CL, Schneider, TR, Tomaka, J, and Wiens, S. (2000) Cardiovascular reactivity and adaptation to recurrent psychological stress: the moderating effects of evaluative observation. Psychophysiology 37(6): 748-56.
78. Kelsey, RM, Ornduff, SR, McCann, CM, and Reiff, S. (2001) Psychophysiological characteristics of narcissism during active and passive coping. Psychophysiology 38(2): 292-303.
79. Kennedy, B, Shen, GH, and Ziegler, MG. (1997) Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system. J Pharmacol Exp Ther 281(1): 291-6.
80. Klatsky, AL, and Armstrong, MA. (1991) Cardiovascular risk factors among Asian Americans living in northern California. Am J Public Health 81(11): 1423-8.
81. Kotanko, P, Binder, A, Tasker, J, DeFreitas, P, Kamdar, S, Clark, AJ, Skrabal, F, and Caulfield, M. (1997) Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension 30(4): 773-6.
82. Kren, V, Pravenec, M, Lu, S, Krenova, D, Wang, JM, Wang, N, Merriouns, T, Wong, A, St Lezin, E, Lau, D, Szpirer, C, Szpirer, J, and Kurtz, TW. (1997) Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest 99(4): 577-81.
83. Krushkal, J, Ferrell, R, Mockrin, SC, Turner, ST, Sing, CF, and Boerwinkle, E. (1999) Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 99(11): 1407-10.
84. Krushkal, J, Xiong, M, Ferrell, R, Sing, CF, Turner, ST, and Boerwinkle, E. (1998) Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 7(9): 1379-83.
85. Kuchel, O. (2003) Mental stress and hypertension, an evolutionary framework: some historical perspectives of the 1960 World Health Organization Prague Hypertension Meeting. J Hypertens 21(3): 639-41.
86. Kuchel, OG, and Kuchel, GA. (1991) Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle. Hypertension 18(6): 709-21.
87. Kurabayashi, T, Carey, DG, and Morrison, NA. (1996) The beta 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45(10): 1358-63.
88. Lander, ES, and Schork, NJ. (1994) Genetic dissection of complex traits. Science 265(5181): 2037-48.
89. Larkin, KT, Knowlton, GE, and D'Alessandri, R. (1990) Predicting treatment outcome to progressive relaxation training in essential hypertensive patients. J Behav Med 13(6): 605-18.
90. Leineweber, K, Buscher, R, Bruck, H, and Brodde, OE. (2004) Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol 369(1): 1-22.
91. Levy, D, DeStefano, AL, Larson, MG, O'Donnell, CJ, Lifton, RP, Gavras, H, Cupples, LA, and Myers, RH. (2000) Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 36(4): 477-83.
92. Li, T, Ball, D, Zhao, J, Murray, RM, Liu, X, Sham, PC, and Collier, DA. (2000) Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 5(4): 452.
93. Li, XX, Bek, M, Asico, LD, Yang, Z, Grandy, DK, Goldstein, DS, Rubinstein, M, Eisner, GM, and Jose, PA. (2001) Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 38(3): 303-8.
94. Lichter, JB, Barr, CL, Kennedy, JL, Van Tol, HH, Kidd, KK, and Livak, KJ. (1993) A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 2(6): 767-73.
95. Light, KC. (2001) Hypertension and the reactivity hypothesis: the next generation. Psychosom Med 63(5): 744-6.
96. Light, KC, Girdler, SS, Sherwood, A, Bragdon, EE, Brownley, KA, West, SG, and Hinderliter, AL. (1999) High stress responsivity predicts later blood pressure only in combination with positive family history and high life stress. Hypertension 33(6): 1458-64.
97. Linhart, A, Jindra, A, Golan, L, Jachymova, M, Sedlacek, K, Peleska, J, Umnerova, V, Bultas, J, Horky, K, and Aschermann, M. (2002) Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men. Br J Biomed Sci 59(2): 90-4.
98. Liu, J, Liu, ZQ, Tan, ZR, Chen, XP, Wang, LS, Zhou, G, and Zhou, HH. (2003) Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74(4): 372-9.
99. Lockette, W, Ghosh, S, Farrow, S, MacKenzie, S, Baker, S, Miles, P, Schork, A, and Cadaret, L. (1995) Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens 8(4 Pt 1): 390-4.
100. Lohmueller, KE, Pearce, CL, Pike, M, Lander, ES, and Hirschhorn, JN. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33(2): 177-82.
101. Mahata, SK, O'Connor, DT, Mahata, M, Yoo, SH, Taupenot, L, Wu, H, Gill, BM, and Parmer, RJ. (1997) Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a non-competitive nicotinic cholinergic antagonist. J Clin Invest 100(6): 1623-33.
102. Makaritsis, KP, Handy, DE, Johns, C, Kobilka, B, Gavras, I, and Gavras, H. (1999) Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension 33(1): 14-7.
103. Mancia, G. (1997) Bjorn Folkow Award Lecture. The sympathetic nervous system in hypertension. J Hypertens 15(12 Pt 2): 1553-65.
104. Mancia, G, Grassi, G, Giannattasio, C, and Seravalle, G. (1999) Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34(4 Pt 2): 724-8.
105. Mannelli, M, Ianni, L, Lazzeri, C, Castellani, W, Pupilli, C, La Villa, G, Barletta, G, Serio, M, and Franchi, F. (1999) In vivo evidence that endogenous dopamine modulates sympathetic activity in man. Hypertension 34(3): 398-402.
106. Marti, A, Corbalan, MS, Martinez-Gonzalez, MA, and Martinez, JA. (2002) TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab 4(6): 428-30.
107. Mason, DA, Moore, JD, Green, SA, and Liggett, SB. (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274(18): 12670-4.
108. McCaffery, JM, Pogue-Geile, MF, Ferrell, RE, Petro, N, and Manuck, SB. (2002) Variability within alpha- and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge. J Hypertens 20(6): 1105-14.
109. Meloni, R, Albanese, V, Ravassard, P, Treilhou, F, and Mallet, J. (1998) A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7(3): 423-8.
110. Michel, MC, Philipp, T, and Brodde, OE. (1992) Alpha- and beta-adrenoceptors in hypertension: molecular biology and pharmacological studies. Pharmacol Toxicol 70(6 Pt 2): S1-10.
111. Neale, BM, and Sham, PC. (2004) The future of association studies: gene-based analysis and replication. Am J Hum Genet 75(3): 353-62.
112. O'Connor, DT, Insel, PA, Ziegler, MG, Hook, VY, Smith, DW, Hamilton, BA, Taylor, PW, and Parmer, RJ. (2000) Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep 2(1): 16-22.
113. O'Connor, DT, Kailasam, MT, Kennedy, BP, Ziegler, MG, Yanaihara, N, and Parmer, RJ. (2002) Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20(7): 1335-45.
114. Ono, K, Iwanaga, Y, Mannami, T, Kokubo, Y, Tomoike, H, Komamura, K, Shioji, K, Yasui, N, Tago, N, and Iwai, N. (2003) Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res 26(9): 685-9.
115. Pausova, Z, Tremblay, J, and Hamet, P. (1999) Gene-environment interactions in hypertension. Curr Hypertens Rep 1(1): 42-50.
116. Peters, WR, MacMurry, JP, Walker, J, Giese, RJ Jr, and Comings, DE. (2003) Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women. Obes Res 11(3): 415-9.
117. Pietruck, F, Moritz, A, Montemurro, M, Sell, A, Busch, S, Rosskopf, D, Virchow, S, Esche, H, Brockmeyer, N, Jakobs, KH, and Siffert, W. (1996) Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated. Circ Res 79(5): 974-83.
118. Poole, J, Davis, H, Snieder, H, and Treiber, F. (2004) Protection from cardiovascular reactivity to stress in women conferred by a beta-2 adrenergic receptor gene polymorphism. Circulation 111(4): E-52.
119. Ranade, K, Jorgenson, E, Sheu, WH, Pei, D, Hsiung, CA, Chiang, FT, Chen, YD, Pratt, R, Olshen, RA, Curb, D, Cox, DR, Botstein, D, and Risch, N. (2002) A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70(4): 935-42.
120. Rice, T, Chagnon, YC, Perusse, L, Borecki, IB, Ukkola, O, Rankinen, T, Gagnon, J, Leon, AS, Skinner, JS, Wilmore, JH, Bouchard, C, and Rao, DC. (2002) A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 51(3): 848-55.
121. Ringel, J, Kreutz, R, Distler, A, and Sharma, AM. (2000) The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am J Hypertens 13(9): 1027-31.
122. Rosendorff, C. (1986) Alpha-adrenoreceptors in hypertension. J Cardiovasc Pharmacol 8 Suppl 2: S3-7.
123. Rosmond, R, Bouchard, C, and Bjorntorp, P. (2002) A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med 251(3): 252-7.
124. Rosmond, R, Rankinen, T, Chagnon, M, Perusse, L, Chagnon, YC, Bouchard, C, and Bjorntorp, P. (2001) Polymorphism in exon 6 of the dopamine D(2) receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men. J Hum Hypertens 15(8): 553-8.
125. Rumantir, MS, Kaye, DM, Jennings, GL, Vaz, M, Hastings, JA, and Esler, MD. (2000) Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36(5): 824-9.
126. Runkel, F, Bruss, M, Nothen, MM, Stober, G, Propping, P, and Bonisch, H. (2000) Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics 10(5): 397-405.
127. Rybakowski, JK, Borkowska, A, Czerski, PM, and Hauser, J. (2001) Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects. Mol Psychiatry 6(6): 718-24.
128. Saab, PG, Llabre, MM, Hurwitz, BE, Schneiderman, N, Wohlgemuth, W, Durel, LA, Massie, C, and Nagel, J. (1993) The cold pressor test: vascular and myocardial response patterns and their stability. Psychophysiology 30(4): 366-73.
129. Sato, M, Soma, M, Nakayama, T, and Kanmatsuse, K. (2000) Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36(2): 183-6.
130. Schanberg, SM, Stone, RA, Kirshner, N, Gunnells, JC, and Robinson, RR. (1974) Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension. Science 183(124): 523-5.
131. Schlaich, MP, Lambert, E, Kaye, DM, Krozowski, Z, Campbell, DJ, Lambert, G, Hastings, J, Aggarwal, A, and Esler, MD. (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43(2): 169-75.
132. Schneider, MP, Klingbeil, AU, Schlaich, MP, Langenfeld, MR, Veelken, R, and Schmieder, RE. (2001) Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension 37(3): 923-7.
133. Schwartz, GL, and Turner, ST. (2004) Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics 4(3): 151-60.
134. Seeman, TE, and McEwen, BS. (1996) Impact of social environment characteristics on neuroendocrine regulation. Psychosom Med 58(5): 459-71.
135. Sharma, P, Hingorani, A, Jia, H, Ashby, M, Hopper, R, Clayton, D, and Brown, MJ. (1998) Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. Hypertension 32(4): 676-82.
136. Siffert, W. (1998) G proteins and hypertension: an alternative candidate gene approach. Kidney Int 53(6): 1466-70.
137. Siffert, W. (2005) G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 56: 17-28.
138. Siffert, W, Forster, P, Jockel, KH, Mvere, DA, Brinkmann, B, Naber, C, Crookes, R, Du, PH. A, Epplen, JT, Fridey, J, Freedman, BI, Muller, N, Stolke, D, Sharma, AM, Al Moutaery, K, Grosse-Wilde, H, Buerbaum, B, Ehrlich, T, Ahmad, HR, Horsthemke, B, Du Toit, ED, Tiilikainen, A, Ge, J, Wang, Y, Rosskopf, D. (1999) Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 10(9): 1921-30.
139. Siffert, W, Rosskopf, D, Moritz, A, Wieland, T, Kaldenberg-Stasch, S, Kettler, N, Hartung, K, Beckmann, S, and Jakobs, KH. (1995) Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest 96(2): 759-66.
140. Siffert, W, Rosskopf, D, Siffert, G, Busch, S, Moritz, A, Erbel, R, Sharma, AM, Ritz, E, Wichmann, HE, Jakobs, KH, and Horsthemke, B. (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18(1): 45-8.
141. Simonen, RL, Rankinen, T, Perusse, L, Leon, AS, Skinner, JS, Wilmore, JH, Rao, DC, and Bouchard, C. (2003) A dopamine D2 receptor gene polymorphism and physical activity in two family studies. Physiol Behav 78(4-5): 751-7.
142. Small, KM, Brown, KM, Forbes, SL, and Liggett, SB. (2001) Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 276(7): 4917-22.
143. Small, KM, Forbes, SL, Rahman, FF, Bridges, KM, and Liggett, SB. (2000) A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 275(30): 23059-64.
144. Small, KM, Wagoner, LE, Levin, AM, Kardia, SL, and Liggett, SB. (2002) Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347(15): 1135-42.
145. Snapir, A, Heinonen, P, Tuomainen, TP, Alhopuro, P, Karvonen, MK, Lakka, TA, Nyyssonen, K, Salonen, R, Kauhanen, J, Valkonen, VP, Pesonen, U, Koulu, M, Scheinin, M, and Salonen, JT. (2001) An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 37(6): 1516-22.
146. Snieder, H, Dong, Y, Barbeau, P, Harshfield, GA, Dalageogou, C, Zhu, H, Carter, ND, and Treiber, FA. (2002) Beta2-adrenergic receptor gene and resting hemodynamics in European and African American youth. Am J Hypertens 15(11): 973-9.
147. Snieder, H, Harshfield, GA, Barbeau, P, Pollock, DM, Pollock, JS, and Treiber, FA. (2002) Dissecting the genetic architecture of the cardiovascular and renal stress response. Biol Psychol 61(1-2): 73-95.
148. Sofowora, GG, Dishy, V, Muszkat, M, Xie, HG, Kim, RB, Harris, PA, Prasad, HC, Byrne, DW, Nair, UB, Wood, AJ, and Stein, CM. (2003) A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 73(4): 366-71.
149. Soma, M, Nakayama, K, Rahmutula, D, Uwabo, J, Sato, M, Kunimoto, M, Aoi, N, Kosuge, K, and Kanmatsuse, K. (2002) Ser9Gly polymorphism in the dopamine D3 receptor gene is not associated with essential hypertension in the Japanese. Med Sci Monit 8(1): CR1-4.
150. Speirs, HJ, Katyk, K, Kumar, NN, Benjafield, AV, Wang, WY, and Morris, BJ. (2004) Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 22(5): 931-6.
151. Steinberg, SF. (1999) The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85(11): 1101-11.
152. Stephens, M, Smith, NJ, and Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4): 978-89.
153. Stober, G, Nothen, MM, Porzgen, P, Bruss, M, Bonisch, H, Knapp, M, Beckmann, H, and Propping, P. (1996) Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 67(6): 523-32.
154. Stoll, M, Kwitek-Black, AE, Cowley, AW Jr, Harris, EL, Harrap, SB, Krieger, JE, Printz, MP, Provoost, AP, Sassard, J, and Jacob, HJ. (2000) New target regions for human hypertension via comparative genomics. Genome Res 10(4): 473-82.
155. Sugaya, K, Nishijima, S, Yamada, T, Miyazato, M, Hatano, T, and Ogawa, Y. (2002) Molecular analysis of adrenergic receptor genes and interleukin-4/ interleukin-4 receptor genes in patients with interstitial cystitis. J Urol 168(6): 2668-71.
156. Sundberg, S, Scheinin, M, Illi, A, Akkila, J, Gordin, A, and Keranen, T. (1993) The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise. Br J Clin Pharmacol 36(5): 451-6.
157. Suzuki, A, Kondo, T, Mihara, K, Furukori, H, Nagashima, U, Ono, S, Otani, K, and Kaneko, S. (2000) Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry 24(7): 1105-13.
158. Suzuki, N, Matsunaga, T, Nagasumi, K, Yamamura, T, Shihara, N, Moritani, T, Ue, H, Fukushima, M, Tamon, A, Seino, Y, Tsuda, K, and Yasuda, K. (2003) Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J Clin Endocrinol Metab 88(3): 1184-7.
159. Tanoue, A, Koba, M, Miyawaki, S, Koshimizu, TA, Hosoda, C, Oshikawa, S, and Tsujimoto, G. (2002) Role of the alpha1D-adrenegric receptor in the development of salt-induced hypertension. Hypertension 40(1): 101-6.
160. Thomas, GN, Tomlinson, B, and Critchley, JA. (2000) Modulation of blood pressure and obesity with the dopamine D2 receptor gene Taq1 polymorphism. Hypertension 36(2): 177-82.
161. Ueda, A, Ozono, R, Oshima, T, Yano, A, Kambe, M, Teranishi, Y, Katsuki, M, and Chayama, K. (2003) Disruption of the type 2 dopamine receptor gene causes a sodium-dependent increase in blood pressure in mice. Am J Hypertens 16(10): 853-8.
162. Velasco, M, Contreras, F, Cabezas, GA, Bolivar, A, Fouillioux, C, and Hernandez, R. (2002) Dopaminergic receptors: a new antihypertensive mechanism. J Hypertens 20 Suppl 3: S55-8.
163. Von Wowern, F, Bengtsson, K, Lindblad, U, Rastam, L, and Melander, O. (2004) Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 43(3): 592-7.
164. von Wowern, F, Bengtsson, K, Lindgren, CM, Orho-Melander, M, Fyhrquist, F, Lindblad, U, Rastam, L, Forsblom, C, Kanninen, T, Almgren, P, Burri, P, Katzman, P, Groop, L, Hulthen, UL, and Melander, O. (2003) A genome wide scan for early onset primary hypertension in Scandinavians. Hum Mol Genet 12(16): 2077-81.
165. Watanabe, H, Xu, J, Bengra, C, Jose, PA, and Felder, RA. (2002) Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 62(3): 790-8.
166. Wei, J, Ramchand, CN, and Hemmings, GP. (1997) Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 99(1): 52-5.
167. Wess, J. (1997) G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. Faseb J 11(5): 346-54.
168. Williams, RB Jr, Suarez, EC, Kuhn, CM, Zimmerman, EA, and Schanberg, SM. (1991) Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation in Type As. Psychosom Med 53(5): 517-27.
169. Williams, RB, Marchuk, DA, Gadde, KM, Barefoot, JC, Grichnik, K, Helms, MJ, Kuhn, CM, Lewis, JG, Schanberg, SM, Stafford-Smith, M, Suarez, EC, Clary, GL, Svenson, IK, and Siegler, IC. (2001) Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med 63(2): 300-5.
170. Williams, SM, Addy, JH, Phillips, JA, 3rd, Dai, M, Kpodonu, J, Afful, J, Jackson, H, Joseph, K, Eason, F, Murray, MM, Epperson, P, Aduonum, A, Wong, LJ, Jose, PA, and Felder, RA. (2000) Combinations of variations in multiple genes are associated with hypertension. Hypertension 36(1): 2-6.
171. Xie, HG, Kim, RB, Stein, CM, Gainer, JV, Brown, NJ, and Wood, AJ. (1999) Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics 9(5): 651-656.
172. Yang, W, White, B, Spicer, EK, Weinstein, BL, and Hildebrandt, JD. (2004) Complex haplotype structure of the human GNAS gene identifies a recombination hotspot centred on a single nucleotide polymorphism widely used in association studies. Pharmacogenetics 14(11): 741-7.
173. Yasuda, K, Matsunaga, T, Moritani, T, Nishikino, M, Gu, N, Yoshinaga, M, Nagasumi, K, Yamamura, T, Aoki, N, and Tsuda, K. (2004) T393C polymorphism of GNAS1 associated with the autonomic nervous system in young, healthy Japanese subjects. Clin Exp Pharmacol Physiol 31(9): 597-601.
174. Yoshioka, K, Yoshida, T, Sakane, N, Umekawa, T, Takahashi, T, Sakai, Y, and Kondo, M. (1996) Association of Trp64Arg mutation of the beta 3-adrenergic receptor gene with NIDDM, current and maximal body mass index. Diabetologia 39(11): 1410-1.
175. Zabetian, CP, Anderson, GM, Buxbaum, SG, Elston, RC, Ichinose, H, Nagatsu, T, Kim, KS, Kim, CH, Malison, RT, Gelernter, J, and Cubells, JF. (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68(2): 515-22.
176. Zabetian, CP, Buxbaum, SG, Elston, RC, Kohnke, MD, Anderson, GM, Gelernter, J, and Cubells, JF. (2003) The Structure of Linkage Disequilibrium at the DBH Locus Strongly Influences the Magnitude of Association between Diallelic Markers and Plasma Dopamine beta-Hydroxylase Activity. Am J Hum Genet 72(6): 1389-400.
177. Zeng, C, Sanada, H, Watanabe, H, Eisner, GM, Felder, RA, and Jose, PA. (2004) Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19(3): 233-46.
178. Zhang, L, Rao, F, Wessel, J, Kennedy, BP, Rana, BK, Taupenot, L, Lillie, EO, Cockburn, M, Schork, NJ, Ziegler, MG, and O'Connor, DT. (2004) Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 19(3): 277-91.
179. Zhu, X, Yan, D, Cooper, RS, Luke, A, Ikeda, MA, Chang, YP, Weder, A, and Chakravarti, A. (2003) Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 13(2): 173-81.
180. Ziegler, MG, Mills, P, and Dimsdale, JE. (1991) Hypertensives' pressor response to norepinephrine. Analysis by infusion rate and plasma levels. Am J Hypertens 4(7 Pt 1): 586-91.